These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30087320)

  • 1. Adaptive mutation F772S-enhanced p7-NS4A cooperation facilitates the assembly and release of hepatitis C virus and is associated with lipid droplet enlargement.
    Duan X; Anwar MI; Xu Z; Ma L; Yuan G; Chen Y; Liu X; Xia J; Zhou Y; Li YP
    Emerg Microbes Infect; 2018 Aug; 7(1):143. PubMed ID: 30087320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.
    Gottwein JM; Jensen SB; Serre SB; Ghanem L; Scheel TK; Jensen TB; Krarup H; Uzcategui N; Mikkelsen LS; Bukh J
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6034-49. PubMed ID: 24060868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.
    Li YP; Ramirez S; Gottwein JM; Scheel TK; Mikkelsen L; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2012 May; 109(18):E1101-10. PubMed ID: 22467829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.
    Mateu G; Donis RO; Wakita T; Bukh J; Grakoui A
    Virology; 2008 Jul; 376(2):397-407. PubMed ID: 18455749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
    Wang Q; Li Y; Liu SA; Xie W; Cheng J
    World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
    Aligeti M; Roder A; Horner SM
    J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
    Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
    J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.
    Gottwein JM; Scheel TK; Jensen TB; Ghanem L; Bukh J
    Gastroenterology; 2011 Sep; 141(3):1067-79. PubMed ID: 21699793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.
    Yi M; Ma Y; Yates J; Lemon SM
    J Virol; 2007 Jan; 81(2):629-38. PubMed ID: 17079282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acidic domain of the hepatitis C virus NS4A protein is required for viral assembly and envelopment through interactions with the viral E1 glycoprotein.
    Roder AE; Vazquez C; Horner SM
    PLoS Pathog; 2019 Feb; 15(2):e1007163. PubMed ID: 30730994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
    Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J
    PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.
    Prentoe J; Verhoye L; Velázquez Moctezuma R; Buysschaert C; Farhoudi A; Wang R; Alter H; Meuleman P; Bukh J
    Gut; 2016 Dec; 65(12):1988-1997. PubMed ID: 26589670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes.
    Phan T; Beran RK; Peters C; Lorenz IC; Lindenbach BD
    J Virol; 2009 Sep; 83(17):8379-95. PubMed ID: 19515772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.
    Jones CT; Murray CL; Eastman DK; Tassello J; Rice CM
    J Virol; 2007 Aug; 81(16):8374-83. PubMed ID: 17537845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.